Merit Medical Systems | MMSI - Equity Capital And Reserves


Merit Medical Systems reported $1.58B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
3M USD 4.75B 119M Dec/2025
Abbott USD 52.13B 1.3B Dec/2025
AngioDynamics USD 185.87M 898K Feb/2025
Anika Therapeutics USD 146.8M 867K Sep/2025
AtriCure USD 491.94M 15.43M Dec/2025
Baxter International USD 6.13B 1.11B Dec/2025
Becton, Dickinson and Co. USD 25.28B 108M Dec/2025
Boston Scientific USD 24.23B 1.58B Dec/2025
Cooper Companies USD 8.36B 124.7M Dec/2025
Dexcom USD 2.75B 19.9M Dec/2025
Edwards Lifesciences USD 10.2B 340.3M Sep/2025
Globus Medical USD 4.57B 174.42M Dec/2025
Haemonetics USD 911.45M 62.28M Dec/2025
Hologic USD 5.25B 197.2M Dec/2025
ICU Medical USD 2.12B 3.42M Dec/2025
Insulet USD 1.52B 131.1M Dec/2025
Integra LifeSciences USD 1.04B 5.89M Dec/2025
J&J USD 78.47B 0 Sep/2025
Medtronic USD 48.86B 964M Sep/2025
Merit Medical Systems USD 1.58B 54.9M Dec/2025
Olympus JPY 773.35B 39.77B Dec/2025
Pfizer USD 92.8B 4.11B Sep/2025
STAAR Surgical USD 344.18M 9.6M Dec/2025
Stryker USD 21.78B 594M Sep/2025
Surmodics USD 118.9M 753K Sep/2024
Tandem Diabetes Care USD 155.17M 22.2M Dec/2025
Teleflex USD 3.12B 697.09M Dec/2025
Terumo JPY 1.52T 84.79B Dec/2025
Zimmer Biomet Holdings USD 12.7B 68.3M Dec/2025